VistaGen Therapeutics (United States)

Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

Lei Yang, Mark H. Soonpaa, Eric Adler et al. · Nature · 2008 · 1.4K citations

Progenitor Cells, Embryonic Stem Cell, Induced Pluripotent Stem Cell +11

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Frank L. Greenway, Ken Fujioka, Raymond A Plodkowski et al. · The Lancet · 2010 · 991 citations

Obesity, Metabolic Syndrome, Non-pharmacological Intervention +9

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)

Caroline M. Apovian, Louis J. Aronne, Domenica Rubino et al. · Obesity · 2013 · 688 citations · Full text

Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes

Donghui Zhang, Ilya Y. Shadrin, Jason T. Lam et al. · Biomaterials · 2013 · 552 citations · Full text

Tissue Engineering, Cardiac Muscle, Engineering +16

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial

Thomas A. Wadden, John P. Foreyt, Gary D. Foster et al. · Obesity · 2010 · 532 citations · Full text